These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35028410)

  • 21. Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non-Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation.
    Reddy VY; Akehurst RL; Amorosi SL; Gavaghan MB; Hertz DS; Holmes DR
    Stroke; 2018 Jun; 49(6):1464-1470. PubMed ID: 29739915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thromboembolism after electrical isolation of the left atrial appendage: a new indication for interventional closure?
    Zender N; Weise FK; Bordignon S; Herrmann E; Konstantinou A; Bologna F; Nagase T; Chen S; Chun KRJ; Schmidt B
    Europace; 2019 Oct; 21(10):1502-1508. PubMed ID: 31230078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Residual stroke risk after left atrial appendage closure in patients with prior oral anticoagulation failure.
    Pracoń R; Zieliński K; Bangalore S; Konka M; Kruk M; Kępka C; Trochimiuk P; Dębski M; Przyłuski J; Kaczmarska E; Dzielińska Z; Kurowski A; Witkowski A; Demkow M
    Int J Cardiol; 2022 May; 354():17-21. PubMed ID: 35219744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indications and Outcome in Patients Undergoing Left Atrial Appendage Closure-The Austrian LAAC Registry.
    Zweiker D; Sieghartsleitner R; Fiedler L; Toth GG; Luha O; Stix G; Gabriel H; Vock P; Lileg B; Strouhal A; Delle-Karth G; Pfeffer M; Aichinger J; Tkalec W; Steinwender C; Sihorsch K; Binder RK; Rammer M; Barbieri F; Mueller S; Verheyen N; Ablasser K; Zirlik A; Scherr D
    J Clin Med; 2020 Oct; 9(10):. PubMed ID: 33066034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combining Watchman left atrial appendage closure and catheter ablation for atrial fibrillation: multicentre registry results of feasibility and safety during implant and 30 days follow-up.
    Phillips KP; Pokushalov E; Romanov A; Artemenko S; Folkeringa RJ; Szili-Torok T; Senatore G; Stein KM; Razali O; Gordon N; Boersma LVA
    Europace; 2018 Jun; 20(6):949-955. PubMed ID: 29106523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined atrial fibrillation ablation and left atrial appendage closure: long-term follow-up from a large multicentre registry.
    Wintgens L; Romanov A; Phillips K; Ballesteros G; Swaans M; Folkeringa R; Garcia-Bolao I; Pokushalov E; Boersma L
    Europace; 2018 Nov; 20(11):1783-1789. PubMed ID: 29547906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of chronic kidney disease on Watchman implantation: experience with 300 consecutive left atrial appendage closures at a single center.
    Xue X; Jiang L; Duenninger E; Muenzel M; Guan S; Fazakas A; Cheng F; Illnitzky J; Keil T; Yu J
    Heart Vessels; 2018 Sep; 33(9):1068-1075. PubMed ID: 29564543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of individual stroke risk on outcome after Amplatzer left atrial appendage closure in patients with atrial fibrillation.
    Häner JD; Fürholz M; Kleinecke C; Galea R; Streit SR; Fankhauser M; Cherni T; Valgimigli M; Windecker S; Meier B; Gloekler S
    Catheter Cardiovasc Interv; 2021 Jun; 97(7):E1002-E1010. PubMed ID: 33022121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of combined catheter ablation and left atrial appendage closure for symptomatic atrial fibrillation in patients with high stroke and bleeding risk.
    Kawakami H; Nolan MT; Phillips K; Scuffham PA; Marwick TH
    Am Heart J; 2021 Jan; 231():110-120. PubMed ID: 32822655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Left Atrial Appendage Closure Versus Oral Anticoagulation in Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Al-Abcha A; Saleh Y; Elsayed M; Elshafie A; Herzallah K; Baloch ZQ; Banga S; Rayamajhi S; Abela GS
    Cardiovasc Revasc Med; 2022 Mar; 36():18-24. PubMed ID: 33903038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic review on left atrial appendage closure with the LAmbre device in patients with non-valvular atrial fibrillation.
    Ali M; Rigopoulos AG; Mammadov M; Torky A; Auer A; Matiakis M; Abate E; Bakogiannis C; Tzikas S; Bigalke B; Sedding D; Noutsias M
    BMC Cardiovasc Disord; 2020 Feb; 20(1):78. PubMed ID: 32050904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Left atrial appendage clusure in nonvalvular atrial fibrillation : Clinical evidence 2017].
    Gloekler S; Hajredini B; Rycerz S; Jäckle S; Jung W
    Herzschrittmacherther Elektrophysiol; 2017 Dec; 28(4):366-380. PubMed ID: 29143099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left atrial appendage closure in atrial fibrillation patients with prior major bleeding or ineligible for oral anticoagulation.
    Wintgens LIS; Vorselaars VMM; Klaver MN; Swaans MJ; Alipour A; Rensing BJWM; Post MC; Boersma LVA
    Neth Heart J; 2019 Dec; 27(12):613-620. PubMed ID: 31187455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex Differences in Outcomes Following Left Atrial Appendage Closure.
    Sanjoy SS; Choi YH; Sparrow RT; Baron SJ; Abbott JD; Azzalini L; Holmes DR; Alraies MC; Tzemos N; Ayan D; Mamas MA; Bagur R
    Mayo Clin Proc; 2021 Jul; 96(7):1845-1860. PubMed ID: 34218859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left Atrial Appendage Closure for Patients with Cerebral Amyloid Angiopathy and Atrial Fibrillation: the LAA-CAA Cohort.
    Schrag M; Mac Grory B; Nackenoff A; Eaton J; Mistry E; Kirshner H; Yaghi S; Ellis CR
    Transl Stroke Res; 2021 Apr; 12(2):259-265. PubMed ID: 32770310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utilization of percutaneous left atrial appendage closure in patients with atrial fibrillation: an update on patient outcomes.
    Kleinecke C; Gloekler S; Meier B
    Expert Rev Cardiovasc Ther; 2020 Aug; 18(8):517-530. PubMed ID: 32654527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left Atrial Appendage Closure Yields Favorable Cardio- and Cerebrovascular Outcomes in Patients With Non-valvular Atrial Fibrillation and Prior Stroke.
    Zhao M; Zhao M; Hou CR; Post F; Herold N; Walsleben J; Meng Z; Yu J
    Front Neurol; 2021; 12():784557. PubMed ID: 35082747
    [No Abstract]   [Full Text] [Related]  

  • 38. Short-term direct oral anticoagulation or dual antiplatelet therapy following left atrial appendage closure in patients with relative contraindications to chronic anticoagulation therapy.
    Faroux L; Cruz-González I; Arzamendi D; Freixa X; Nombela-Franco L; Peral V; Caneiro-Queija B; Mangieri A; Trejo-Velasco B; Asmarats L; Regueiro A; McInerney A; Mas-Lladó C; Estevez-Loureiro R; Laricchia A; O'Hara G; Rodés-Cabau J
    Int J Cardiol; 2021 Jun; 333():77-82. PubMed ID: 33647365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left atrial appendage closure after cryoballoon ablation in patients with atrial fibrillation.
    Liu J; Xia Y; Zhang H; Li X; Zhang S; Fang P
    Herz; 2021 Apr; 46(Suppl 1):82-88. PubMed ID: 32002565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Net Clinical Benefit of Left Atrial Appendage Closure Versus Warfarin in Patients With Atrial Fibrillation: A Pooled Analysis of the Randomized PROTECT-AF and PREVAIL Studies.
    Brouwer TF; Whang W; Kuroki K; Halperin JL; Reddy VY
    J Am Heart Assoc; 2019 Dec; 8(23):e013525. PubMed ID: 31752643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.